This bispecific antibody is composed of two single domain antibodies targeting HER3 and HER2/neu, respectively. It is capable of mediating a reduction in the quantity of HER2/neu and HER3 on the surface of tumor cells, which is a similar mechanism to internalization.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for NANO-MZ002. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.